Hospital Price Disclosure Bill Introduced

May 2005
hfm (Healthcare Financial Management);May2005, Vol. 59 Issue 5, p16
Trade Publication
This article reports that the first effort to regulate hospital price disclosure was recently introduced in the U.S. House of Representatives. The Hospital Price Disclosure Act, sponsored by Representative Dan Lipinski and Representative Bob Inglis, would require hospitals to report to HHS the average and median prices of their 25 most common inpatient and outpatient procedures and 50 most prescribed medications. Hospitals would have 45 days following the end of each calendar quarter to report their prices and the frequency with which they perform a procedure or administer a drug in an inpatient setting.


Related Articles

  • Priceless. Fong, Tony // Modern Healthcare;3/28/2005, Vol. 35 Issue 13, p6 

    Focuses on the little interest shown by healthcare consumers in chargemasters or list of prices for services at hospitals. Federal legislation introduced by Illinois Representative Dan Lipinski and South Carolina Representative Bob Inglis on health service price information; Results of the...

  • Washington Insider. Doerflinger, Richard M. // National Catholic Bioethics Quarterly;Sep2010, Vol. 10 Issue 3, p439 

    The article offers updates on topics related to health care in the U.S. Legislators Joe Pitts and Dan Lipinski have introduced the Protect Life Act to address the deficiencies of the Patient Protection and Affordable Care Act (PPACA). The embryonic stem cell research still lacks evidence on...

  • House Committee Continues Patient Billing Investigation.  // hfm (Healthcare Financial Management);Jun2005, Vol. 59 Issue 6, p14 

    Reports that the U.S. House Energy and Commerce Committee has sent a follow-up letter to 10 large hospital systems requesting additional information on patient billing issues. Procedure for the presentation of hospital charges; Computation of the gross charges; Continuation of the investigation...

  • Report paints bleak picture of acute services. McMillan, Ian // Mental Health Practice;May2004, Vol. 7 Issue 8, p4 

    Reports on the state of acute inpatient care services in Great Britain. Failure of patients to receive atypical or second generation antipsychotic medication; Complaint of a lack of privacy, dignity and comfort; Effect of record keeping, ward rounds and observations on staff time and their...

  • TURNING A CHEMOTHERAPY VARIANCE INTO A POSITIVE PRACTICE. Long, Mary Ann; Stoberman, Gisela; Mc-Cabe, Anita; Wieslo, Pamela; Nokic, Merima // Oncology Nursing Forum;Mar2006, Vol. 33 Issue 2, p474 

    Chemotherapy is a mainstay for treatment of a wide range of oncological conditions. Chemotherapy agents are high-risk medications that can cause significant toxicities, adverse reactions and side effects. At Roswell Park Cancer Institute, a chemotherapy variance (at RPCI, a medication error is...

  • 'Fixing' Health Care Reform.  // America;2/7/2011, Vol. 204 Issue 3, p6 

    The article reports on the efforts of the bishops to strongly support the No Taxpayer Funding for Abortion Act that was introduced on January 20, 2011 in the U.S. Democrat Representative Dan Lipinski mentions that the law would prevent taxpayer funding of abortion through annual riders. It...

  • The Politics of Medicare and Prescription Drug Costs. Hislop III, Reginald // Human Rights;Spring2001, Vol. 28 Issue 2, p15 

    The article discusses the Medicare program and prescription drug costs in the U.S. According to the Office of Management and Budget, Medicare presently covers an average of 53 percent of a beneficiary's annual medical expenses. The prescription drug benefit proposals target financial assistance...

  • Methods for Assessing the Preventability of Adverse Drug Events: A Systematic Review. Hakkarainen, Katja Marja; Sundell, Karolina Andersson; Petzold, Max; Hägg, Staffan // Drug Safety;2012, Vol. 35 Issue 2, p105 

    Background: Preventable adverse drug events (ADEs) are common in both outpatient and inpatient settings. However, the proportion of preventable ADEs varies considerably in different studies, even when conducted in the same setting, and methods for assessing the preventability of ADEs are...

  • THE EFFICACY OF FORCED TREATMENT. Koerner, Harald Hans // Journal of Drug Issues;Spring2002, Vol. 32 Issue 2, p543 

    The author describes the German drug policy approach of �Therapy instead of punishment� and its legal ramifications. The substantive and formal requirements of the pertinent laws and their interpretations are identified. Four options are considered: (1) deferral of prison detention in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics